Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Clinical trial NCT02918968 · COMPLETED
Trial details
- NCT number
- NCT02918968
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-02
- Primary completion
- 2020-03-27
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.